Invasive Streptococcus pneumoniae in France: Antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 9, 2004, Pages 3636-3639

  Decousser, Jean Winoc ^a   Pina, Patrick ^b   Viguier, Florent ^a   Picot, Franc ^a   Courvalin, Patrice ^c   Allouch, Pierre ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b Hôpital de Plaisir Grignon   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; FRANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADULT; AMOXICILLIN; CHILD; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 4344673890     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.9.3636-3639.2004     Document Type: Article

References (30)

1. Adam, D. 2002. Global antibiotic resistance in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl.):1-5.
2. Anton, N., R. Blazquez, J. L. Gomez-Garces, and J. I. Alos. 2001. Study of vancomycin tolerance in 120 strains of Streptococcus pneumoniae isolated in 1999 in Madrid, Spain. J. Antimicrob. Chemother. 47:902-903.
3. Bedos, J. P., S. Chevret, C. Chastang, P. Geslin, and B. Regnier. 1996. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin. Infect. Dis. 22:63-72.
4. Decousser, J. W., P. Y. Allouch, P. Courvalin, R. Leclercq, and the Study Group. 2002. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey. Int. J. Antimicrob. Agents 20:186-195.
5. Decousser, J. W., O. Ovetchkine, A. Collignon, C. Chaplain, E. Estrangin, A. Fremaux, P. Reinert, P. Foucaud, J.-C. Ghnassia, R. Cohen, J. Gaudelus, and P.-Y. Allouch. 2004. Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae strains isolated from children in the Ile-De-France area. Eur. J. Clin. Microbiol. Infect. Dis. 23:27-33.
6. Doit, C., C. Loukil, P. Geslin, and E. Bingen. 2002. Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children. J. Clin. Microbiol. 40:2994-2998.
7. Doit, C., B. Picard, C. Loukil, P. Geslin, and E. Bingen. 2000. Molecular epidemiology survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France. J. Infect. Dis. 181:1971-1978.
8. Ferroni, A., L. Nguyen, P. Gehanno, I. Boucot, and P. Berche. 1996. Clonal distribution of penicillin-resistant Streptococcus pneumoniae 23F in France. J. Clin. Microbiol. 34:2707-2712.
9. Fitoussi, F., C. Doit, P. Geslin, N. Brahimi, and E. Bingen. 2001. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France. Antimicrob. Agents Chemother. 45:63663-63668.
10. Henriques Normark, B., M. Kalin, A. Ortqvist, T. Akerlund, B. O. Liljequist, J. Hedlund, S. B. Svenson, J. Zhou, B. G. Spratt, S. Normark, and G. Kallenius. 2001. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J. Infect. Dis. 184:861-869.
11. Henriques Normark, B., R. Novak, A. Ortqvist, G. Kallenius, E. Tuomanen, and S. Normark. 2001. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin. Infect. Dis. 32:552-558.
12. Institut de Veille Sanitaire. 2002. Surveillance nationale des maladies infectieuses EPIBAC 1991-2000. Infections invasives à H. influenzae, L. monocytogenes, N. meningitidis, S. pneumoniae, S. agalactiae et S. pyogenes en France en 2000. [Online.] http://www.invs.sante.fr/publications/default.htm.
13. Kalin, M., A. Ortqvist, M. Almela, E. Aufwerber, R. Dwyer, B. Henriques, C. Jorup, I. Julander, T. J. Marrie, M. A. Mufson, R. Riquelme, A. Thalme, A. Torres, and M. A. Woodhead. 2000. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J. Infect. Dis. 182:840-847.
14. Kaplan, S. L., and E. O. Mason, Jr. 1998. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Rev. 11:628-644.
15. Konradsen, H. B., and M. S. Kaltoft. 2002. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin. Diagn. Lab. Immunol. 9:358-365.
16. Lim, S., D. Bast, A. McGeer, J. de Azavedo, and D. E. Low. 2003. Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerg. Infect. Dis. 9:833-837.
17. Maugein, J., D. Guillemot, M. J. Dupont, T. Fosse, G. Laurans, M. Roussel-Delvallez, J. Thierry, M. Vergnaud, M. Weber, and B. Poirier. 2003. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin. Microbiol. Infect. 9:280-288.
18. McCullers, J. A., B. K. English, and R. Novak. 2000. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J. Infect. Dis. 181:369-373.
19. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
20. Moissenet, D., M. Valcin, V. Marchand, E. N. Garabedian, P. Geslin, A. Garbarg-Chenon, and H. Vu-Thien. 1997. Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital. J. Clin. Microbiol. 351:298-301.
21. Nagai, K., Y. Shibasaki, K. Hasegawa, T. A. Davies, M. R. Jacobs, K. Ubukata, and P. C. Appelbaum. 2001. Evaluation of PCR primers to screen for S. pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J. Antimicrob. Chemother. 48:915-918.
22. National Committee for Clinical Laboratory Standards. 2001. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
23. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Ortega, M., F. Marco, A. Soriano, E. Garcia, J. A. Martinez, and J. Mensa. 2003. Lack of vancomycin tolerance in S. pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001. Antimicrob. Agents Chemother. 47: . 1976-1978.
25. Richardson, D. C., D. Bast, A. McGeer, and D. E. Low. 2001. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:1911-1914.
26. Richter, S. S., K. P. Heilmann, S. L. Coffman, H. K. Huynh. A. B. Brueggemann, M. A. Pfaller, and G. V. Doern. 2002. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin. Infect. Dis. 34:330-339.
27. Sahm, D. F., J. A. Karlowsky, L. J. Kelly, I. A. Critchley, M. E. Jones, C. Thornsberry, Y. Mauriz, and J. Kahn. 2001. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob. Agents Chemother. 45:1037-1042.
28. Soussy, C. J., M. Cluzel, M. C. Ploy, M. D. Kitzis, C. Morel, A. Bryskier, and P. Courvalin. 1999. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study. J. Antimicrob. Chemother. 43(Suppl. C):43-50.
29. Spratt, B. G., and B. M. Greenwood. 2000. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356:1210-1211.
30. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 9:2233-2239.